We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Proteros Biostructures Achieve Milestone in Fragment-Based Protein Crystallography Collaboration

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Proteros biostructures GmbH has announced that the first milestone of their research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography has been successfully achieved, triggering the associate milestone payment.

In the collaboration, which started in June 2006, Proteros applies its target know-how, industrial process and proprietary Free Mounting System (FMS™) and Picodropper™ technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs to Bayer HealthCare. Under the terms of the agreement Proteros will also receive a copy of the jointly selected fragment library for its own use.

”We are pleased to proof that Proteros’ experience, has allowed delivery of valuable protein-fragment-structures to Bayer HealthCare within the envisioned time frame”, stated Torsten Neuefeind, Ph.D., Chief Executive Officer of Proteros.